By
Drug Target Review2024-09-03T12:00:07
The findings could aid the design of more stable drugs and improve the understanding of diseases linked to peptide aggregation.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2025-09-18T12:00:00
Sponsored by Benchling
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2025-05-14T14:30:00
Sponsored by Abzena
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
Site powered by Webvision Cloud